PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31285784-0	2019	The Effect of 600 mg Alpha-lipoic Acid Supplementation on Oxidative Stress, Inflammation, and RAGE in Older Adults with Type 2 Diabetes Mellitus.	Thioctic Acid	21-38	advanced glycosylation end-product specific receptor	Homo sapiens	94-98	
23780308-0	2013	Epigallocatechin-3-gallate combined with alpha lipoic acid attenuates high glucose-induced receptor for advanced glycation end products (RAGE) expression in human embryonic kidney cells.	Thioctic Acid	41-58	advanced glycosylation end-product specific receptor	Homo sapiens	137-141	
23780308-5	2013	Both EGCG and ALA decreased HG-induced receptor of advanced glycation end products (RAGE) mRNA and protein expressions in HEK cells.	Thioctic Acid	14-17	advanced glycosylation end-product specific receptor	Homo sapiens	84-88	
31285784-11	2019	Our findings suggest that the administration of ALA at a dose of 600 mg/day for six months has a similar effect to that of placebo on oxidative stress, inflammation, and RAGE in older adults with T2DM.	Thioctic Acid	48-51	advanced glycosylation end-product specific receptor	Homo sapiens	170-174	
12453911-13	2002	The AGE- and CML-dependent activation of NF-kappaBp65 and NF-kappaB-dependent IL-6 expression could be inhibited using the soluble form of the receptor for AGEs (RAGE) (soluble RAGE [sRAGE]), RAGE-specific antibody, or the antioxidant thioctic acid.	Thioctic Acid	235-248	advanced glycosylation end-product specific receptor	Homo sapiens	162-166	
12453911-13	2002	The AGE- and CML-dependent activation of NF-kappaBp65 and NF-kappaB-dependent IL-6 expression could be inhibited using the soluble form of the receptor for AGEs (RAGE) (soluble RAGE [sRAGE]), RAGE-specific antibody, or the antioxidant thioctic acid.	Thioctic Acid	235-248	advanced glycosylation end-product specific receptor	Homo sapiens	177-181	
12453911-13	2002	The AGE- and CML-dependent activation of NF-kappaBp65 and NF-kappaB-dependent IL-6 expression could be inhibited using the soluble form of the receptor for AGEs (RAGE) (soluble RAGE [sRAGE]), RAGE-specific antibody, or the antioxidant thioctic acid.	Thioctic Acid	235-248	advanced glycosylation end-product specific receptor	Homo sapiens	177-181